Kezar Life Sciences, Inc. (KZR) Times Interest Earned (2017 - 2026)

Kezar Life Sciences has reported Times Interest Earned for 10 years, with the latest figure at -$7.58 in Q1 2026.

• Quarterly Times Interest Earned rose 85.09% year-over-year to -$7.58 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$37.95 (up 41.63% YoY) and the FY2025 annual result came in at -$0.54, up 39.32% from the prior year.
• Times Interest Earned retreated to -$7.58 in Q1 2026 per KZR's latest filing, from $36.02 in the prior quarter.
• Over five years, Times Interest Earned peaked at $36.02 in Q4 2025 and troughed at -$210.91 in Q4 2023.
• A 5-year average of -$31.5 and a median of -$24.09 in 2022 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2023 and 2025: Times Interest Earned plunged 5161.62% in 2023, then soared 164.98% in 2025.
• Over 5 years, Times Interest Earned stood at -$50.08 in 2022, then slumped by 321.1% to -$210.91 in 2023, then jumped by 73.72% to -$55.43 in 2024, then jumped by 164.98% to $36.02 in 2025, then slumped by 121.04% to -$7.58 in 2026.
• According to Business Quant data, Times Interest Earned over the past three periods registered -$7.58, $36.02, and -$3.41 for Q1 2026, Q4 2025, and Q3 2025 respectively.